跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Trigonelline
首页
药物
Trigonelline
Trigonelline
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Trigonelline as a muscle stimulant
US 8323707 B2
申请人: FRIEDEL ANGELIKA
优先权: 2009
US
7 件公开
EP 2269607 A1
申请人: DSM IP ASSETS BV
优先权: 2009
EP
Synergistic composition for the treatment of diabetes mellitus
US 7141254 B2
申请人: INDUS BIOTECH PVT LTD
优先权: 2004
US
6 件公开
US 7674486 B2
申请人: INDUS BIOTECH PVT LTD
优先权: 2006
US
2 件公开
US 7736676 B2
申请人: INDUS BIOTECH PVT LTD
优先权: 2006
US
2 件公开
COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) FOR TREATING OR PREVENTING PHYSIOLOGICAL DISORDERS OR STATES
EP 3993770 A1
申请人: NESTLE SA
优先权: 2019
CN
EP
US
WO
5 件公开
Pharmaceutical composition having dopaminergic activity
US 8633229 B2
申请人: BHASKARAN SUNIL
优先权: 2008
US
4 件公开
COMPOSITIONS COMPRISING TRIGONELLINE AND UROLITHIN
EP 4719378 A1
申请人: AMAZENTIS SA
优先权: 2023
CN
EP
WO
3 件公开
METHODS AND COMPOSITIONS COMPRISING TRIGONELLINE FOR TREATING MUSCLE DECLINE AND A KIDNEY DYSFUNCTION
EP 4734992 A1
申请人: NESTLE SA
优先权: 2023
CN
EP
WO
3 件公开
Process for the preparation of trigonelline or pharmaceutically acceptable salts thereof
US 12630513 B2
申请人: LAURUS LABS LTD
优先权: 2020
US
WO
3 件公开
A MULTIFUNCTIONAL VULNERARY COMPOSITION
US 20260166096 A1
申请人: ALVARADO CARLOS
优先权: 2023
US
WO
2 件公开
Triggerable Compositions For Two-Stage, Controlled Release of Proactive Chemistry
US 2015118294 A1
申请人: KIMBERLY CLARK CO
优先权: 2013
US
2 件公开
Tropane alkaloids and trigonelline combinations and methods for administering the same
US 2009156634 A1
申请人: IOVATE T & P INC
优先权: 2007
US
第 1 / 6 页
上一页
下一页
药物
反馈